Viatris (VTRS) Debt Ratio (2019 - 2026)
Viatris (VTRS) posted quarterly Debt Ratio of 0.39 for Q1 2026, down 5.5% year-over-year from 0.41 in Q1 2025, and little changed quarter-over-quarter from 0.39 in Q4 2025.
Viatris (VTRS) Debt Ratio (2019 - 2026) Analysis & Trends
Viatris' Debt Ratio history runs 8 years deep, the most recent figure standing at 0.39 for Q1 2026.
- In Q1 2026, Debt Ratio fell 5.5% year-over-year to 0.39; the TTM figure through Mar 2026 stood at 0.39 (down 5.5% YoY), while the FY2025 annual figure was 0.39, up 14.56% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.39, roughly flat from 0.39 in the prior quarter.
- The five-year high for Debt Ratio was 0.41 in Q1 2025, with the low at 0.34 in Q4 2024.
- The 5-year median for Debt Ratio is 0.38 (2024), against an average of 0.38.
- The sharpest annual moves came in 2023 and 2025: Debt Ratio decreased 12.48% in 2023, then grew 14.56% in 2025.
- Viatris' Debt Ratio stood at 0.39 in 2022, then retreated by 1.37% to 0.38 in 2023, then fell by 10.99% to 0.34 in 2024, then climbed by 14.56% to 0.39 in 2025, then increased by 0.46% to 0.39 in 2026.
- Business Quant data shows VTRS's Debt Ratio at 0.39 in Q1 2026, 0.39 in Q4 2025, and 0.38 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 0.12 |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | 0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.38 |
| Mar 31, 2026 | 0.39 |
| Dec 31, 2025 | 0.39 |
| Sep 30, 2025 | 0.38 |
| Jun 30, 2025 | 0.38 |
| Mar 31, 2025 | 0.41 |
| Dec 31, 2024 | 0.34 |
| Sep 30, 2024 | 0.36 |
| Jun 30, 2024 | 0.36 |
| Mar 31, 2024 | 0.38 |
| Dec 31, 2023 | 0.38 |
| Sep 30, 2023 | 0.35 |
| Jun 30, 2023 | 0.35 |
| Mar 31, 2023 | 0.37 |
| Dec 31, 2022 | 0.39 |
| Sep 30, 2022 | 0.40 |
| Jun 30, 2022 | 0.39 |
| Mar 31, 2022 | 0.36 |
| Dec 31, 2021 | 0.39 |
| Sep 30, 2021 | 0.39 |